Parp1 deficient mice are protected from streptozotocin-induced diabetes but not caerulein-induced pancreatitis, independent of the induction of Reg family genes

Regulatory Peptides

Volumn 186, Issue , 2013, Pages 83-91

  Li, Bing ^a   Luo, Chen ^a,b   Chowdhury, Subrata ^a   Gao, Zu Hua ^a   Liu, Jun Li ^a,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c Montreal Diabetes Research Centre   (Canada)

Author keywords

Acute pancreatitis; Diabetes; Pancreatic acini; Pancreatic islets; Parp1; Reg proteins

Indexed keywords

INSULIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;

ACINAR CELL; ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DISEASE SEVERITY; GENE; GENE DELETION; INSULIN BLOOD LEVEL; KNOCKOUT MOUSE; MALE; MOUSE; MULTIGENE FAMILY; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREATITIS; PRIORITY JOURNAL; REG GENE; REG1 GENE; REG2 GENE; REG3ALPHA GENE; REG3BETA GENE; STREPTOZOCIN DIABETES; UPREGULATION;

ACUTE PANCREATITIS; DIABETES; PANCREATIC ACINI; PANCREATIC ISLETS; PARP1; REG PROTEINS;

ANIMALS; CERULETIDE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TRANSPORTER TYPE 2; INSULIN-SECRETING CELLS; LITHOSTATHINE; MALE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; PANCREATITIS; POLY(ADP-RIBOSE) POLYMERASES; STREPTOZOCIN; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84883707984     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2013.07.005     Document Type: Article

References (48)

1. Yamamoto H., Uchigata Y., Okamoto H. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 1981, 294:284-286.
2. Burkart V., Wang Z.Q., Radons J., Heller B., Herceg Z., Stingl L., Wagner E.F., Kolb H. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med 1999, 5:314-319.
3. Masutani M., Suzuki H., Kamada N., Watanabe M., Ueda O., Nozaki T., Jishage K., Watanabe T., Sugimoto T., Nakagama H., Ochiya T., Sugimura T. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 1999, 96:2301-2304.
4. Pieper A.A., Brat D.J., Krug D.K., Watkins C.C., Gupta A., Blackshaw S., Verma A., Wang Z.Q., Snyder S.H. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 1999, 96:3059-3064.
5. Gravitz L. Microbiome: the critters within. Nature 2012, 485:S12-S13.
6. Satomura Y., Sawabu N., Mouri I., Yamakawa O., Watanabe H., Motoo Y., Okai T., Ito T., Kaneda K., Okamoto H. Measurement of serum PSP/reg-protein concentration in various diseases with a newly developed enzyme-linked immunosorbent assay. J Gastroenterol 1995, 30:643-650.
7. Akiyama T., Takasawa S., Nata K., Kobayashi S., Abe M., Shervani N.J., Ikeda T., Nakagawa K., Unno M., Matsuno S., Okamoto H. Activation of Reg gene, a gene for insulin-producing beta-cell regeneration: poly(ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly(ADP-ribosyl)ation. Proc Natl Acad Sci U S A 2001, 98:48-53.
8. Mazzon E., Genovese T., Di Paola R., Muia C., Crisafulli C., Malleo G., Esposito E., Meli R., Sessa E., Cuzzocrea S. Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein. Eur J Pharmacol 2006, 549:149-156.
9. Mota R.A., Sanchez-Bueno F., Saenz L., Hernandez-Espinosa D., Jimeno J., Tornel P.L., Martinez-Torrano A., Ramirez P., Parrilla P., Yelamos J. Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury. Lab Invest 2005, 85:1250-1262.
10. Gironella M., Folch-Puy E., LeGoffic A., Garcia S., Christa L., Smith A., Tebar L., Hunt S.P., Bayne R., Smith A.J., Dagorn J.C., Closa D., Iovanna J.L. Experimental acute pancreatitis in PAP/HIP knock-out mice. Gut 2007, 56:1091-1097.
11. Graf R., Schiesser M., Lussi A., Went P., Scheele G.A., Bimmler D. Coordinate regulation of secretory stress proteins (PSP/reg, PAP I, PAP II, and PAP III) in the rat exocrine pancreas during experimental acute pancreatitis. J Surg Res 2002, 105:136-144.
12. Carrère J., Guy-Crotte O., Figarella C. Human pancreatic reg protein: immunoenzymatic assay and molecular form in serum. Clin Chim Acta 1998, 273:185-194.
13. Liu J.L., Cui W., Li B., Lu Y. Possible roles of reg family proteins in pancreatic islet cell growth. Endocr Metab Immune Disord Drug Targets 2008, 8:1-10.
14. Wang Y., Jacovetti C., Li B., Siddique T., Xiong X., Yin H., Wang M., Zhao H., Liu J.-L. Coordinated age-dependent and pancreatic-specific expression of mouse Reg2, Reg3α and Reg3β genes. Growth Factors 2011, 29:1-10.
15. Bluth M.H., Patel S.A., Dieckgraefe B.K., Okamoto H., Zenilman M.E. Pancreatic regenerating protein (reg I) and reg I receptor mRNA are upregulated in rat pancreas after induction of acute pancreatitis. World J Gastroenterol 2006, 12:4511-4516.
16. Lu Y., Ponton A., Okamoto H., Takasawa S., Herrera P.L., Liu J.-L. Activation of the Reg family genes by pancreatic-specific IGF-I gene deficiency and after streptozotocin-induced diabetes in mouse pancreas. Am J Physiol Endocrinol Metab 2006, 291:E50-E58.
17. Chang T.J., Weaver J.R., Bowman A., Leone K., Raab R., Vinik A.I., Pittenger G.L., Taylor-Fishwick D.A. Targeted expression of INGAP to beta cells enhances glucose tolerance and confers resistance to streptozotocin-induced hyperglycemia. Mol Cell Endocrinol 2011, 335:104-109.
18. Rosenberg L., Lipsett M., Yoon J.W., Prentki M., Wang R., Jun H.S., Pittenger G.L., Taylor-Fishwick D., Vinik A.I. A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice. Ann Surg 2004, 240:875-884.
19. Takasawa S., Ikeda T., Akiyama T., Nata K., Nakagawa K., Shervani N.J., Noguchi N., Murakami-Kawaguchi S., Yamauchi A., Takahashi I., Tomioka-Kumagai T., Okamoto H. Cyclin D1 activation through ATF-2 in Reg-induced pancreatic beta-cell regeneration. FEBS Lett 2006, 580:585-591.
20. Taylor-Fishwick D.A., Bowman A., Hamblet N., Bernard P., Harlan D.M., Vinik A.I. Islet neogenesis associated protein transgenic mice are resistant to hyperglycemia induced by streptozotocin. J Endocrinol 2006, 190:729-737.
21. Liu L., Liu J.L., Srikant C.B. Reg2 protects mouse insulinoma cells from streptozotocin-induced mitochondrial disruption and apoptosis. Growth Factors 2010, 28:370-378.
22. Cui W., De Jesus K., Zhao H., Takasawa S., Shi B., Srikant C.B., Liu J.L. Overexpression of Reg3alpha increases cell growth and the levels of cyclin D1 and CDK4 in insulinoma cells. Growth Factors 2009, 27:195-202.
23. Xiong X., Wang X., Li B., Chowdhury S., Lu Y., Srikant C.B., Ning N., Liu J.-L. Pancreatic islet-specific overexpression of Reg3β protein induced the expression of pro-islet genes and protected mice against streptozotocin-induced diabetes. Am J Physiol Endocrinol Metab 2011, 300:E669-E680.
24. Li B., Wang X., Liu J.-L. Pancreatic acinar-specific overexpression of Reg2 gene offered no protection against either experimental diabetes or pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol 2010, 299:G413-G421.
25. Terazono K., Uchiyama Y., Ide M., Watanabe T., Yonekura H., Yamamoto H., Okamoto H. Expression of reg protein in rat regenerating islets and its co-localization with insulin in the beta cell secretory granules. Diabetologia 1990, 33:250-252.
26. Pieper A.A., Brat D.J., Krug D.K., Watkins C.C., Gupta A., Blackshaw S., Verma A., Wang Z.-Q., Snyder S.H. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci 1999, 96:3059-3064.
27. Charron M.J., Bonner-Weir S. Implicating PARP and NAD+ depletion in type I diabetes. Nat Med 1999, 5:269-270.
28. Okamoto H., Takasawa S. Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in beta-cells. Diabetes 2002, 51(Suppl. 3):S462-S473.
29. Ohno T., Ishii C., Kato N., Ito Y., Shimizu M., Tomono S., Murata K., Kawazu S. Increased expression of a regenerating (reg) gene protein in neonatal rat pancreas treated with streptozotocin. Endocr J 1995, 42:649-653.
30. Luo C., Li B., Liu L., Yin H.-P., Wang M., Liu J.-L. Transcriptional activation of Reg2 and Reg3β genes by glucocorticoids and interleukin-6 in pancreatic acinar and islet cells. Mol Cell Endocrinol 2013, 365:187-196.
31. Schnedl W.J., Ferber S., Johnson J.H., Newgard C.B. STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells. Diabetes 1994, 43:1326-1333.
32. Xu J., Zhang L., Chou A., Allaby T., Belanger G., Radziuk J., Jasmin B.J., Miki T., Seino S., Renaud J.M. K-ATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity. Am J Physiol Endocrinol Metab 2008, 294:E326-E335.
33. Bedard K., Bedard J., Rocheleau G., Ferland G., Gaudreau P. Aging and diets regulate the rat anterior pituitary and hypothalamic transcriptome. Neuroendocrinology 2013, 97:146-159.
34. Sarruf D.A., Bonner-Weir S., Schwartz M.W. New clues to bariatric surgery's benefits. Nat Med 2012, 18:860-861.
35. Clemmons D.R. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am 2012, 41:425-443.
36. Wesche P.L., Gaffney D.J., Keightley P.D. DNA sequence error rates in GenBank records estimated using the mouse genome as a reference. DNA Seq 2004, 15:362-364.
37. Kuemmerle J.F. Insulin-like growth factors in the gastrointestinal tract and liver. Endocrinol Metab Clin North Am 2012, 41:409-423.
38. Liu J.L., Cui W. Which gene, Reg2 or Reg3beta, was targeted that affected liver regeneration?. Hepatology 2007, 45:1584-1585.
39. Rafaeloff R., Pittenger G.L., Barlow S.W., Qin X.F., Yan B., Rosenberg L., Duguid W.P., Vinik A.I. Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J Clin Invest 1997, 99:2100-2109.
40. Viterbo D., Callender G.E., DiMaio T., Mueller C.M., Smith-Norowitz T., Zenilman M.E., Bluth M.H. Administration of anti-Reg I and anti-PAPII antibodies worsens pancreatitis. J Pancreas 2009, 10:15-23.
41. De Vos A., Heimberg H., Quartier E., Huypens P., Bouwens L., Pipeleers D., Schuit F. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 1995, 96:2489-2495.
42. Hosokawa M., Dolci W., Thorens B. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin. Biochem Biophys Res Commun 2001, 289:1114-1117.
43. Holly J.M.P., Perks C.M. Insulin-like growth factor physiology: what we have learned from human studies. Endocrinol Metab Clin North Am 2012, 41:249-263.
44. Stefater M.A., Wilson-Perez H.E., Chambers A.P., Sandoval D.A., Seeley R.J. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev 2012, 33:595-622.
45. Efrat S., Russ H.A. Making β cells from adult tissues. Trends Endocrinol Metab 2012, 23:278-285.
46. Bai P., Canto C., Brunyánszki A., Huber A., Szántó M., Cen Y., Yamamoto H., Houten Sander M., Kiss B., Oudart H., Gergely P., Menissier-de Murcia J., Schreiber V., Sauve Anthony A., Auwerx J. PARP-2 Regulates SIRT1 Expression and Whole-Body Energy Expenditure. Cell Metab 2011, 13:450-460.
47. Bai P., Canto C., Oudart H., Brunyanszki A., Cen Y., Thomas C., Yamamoto H., Huber A., Kiss B., Houtkooper R.H., Schoonjans K., Schreiber V., Sauve A.A., Menissier-de Murcia J., Auwerx J. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 2011, 13:461-468.
48. Wang Z.Q., Auer B., Stingl L., Berghammer H., Haidacher D., Schweiger M., Wagner E.F. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 1995, 9:509-520.